We are live on ! Find out more
OCBV

Ownership Capital B.V. Portfolio holdings

AUM $178M
1-Year Est. Return 4.75%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+4.75%
3 Year Est. Return
+62.8%
5 Year Est. Return
+49.32%
10 Year Est. Return
+389.93%
AUM
$5.71B
AUM Growth
+$22.6M
Cap. Flow
-$94.8M
Cap. Flow %
-1.66%
Top 10 Hldgs %
65.91%
Holding
21
New
1
Increased
2
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
MSCI icon
MSCI
MSCI
+$135M
2
VEEV icon
Veeva Systems
VEEV
+$39M
3
RMD icon
ResMed
RMD
+$24.7M

Top Sells

Rank Stock Value
1
MRVI icon
Maravai LifeSciences
MRVI
+$53.2M
2
EW icon
Edwards Lifesciences
EW
+$39.2M
3
ICE icon
Intercontinental Exchange
ICE
+$36.8M
4
TW icon
Tradeweb Markets
TW
+$33.8M
5
MKTX icon
MarketAxess Holdings
MKTX
+$32.9M

Sector Composition

Rank Sector Weight
1 Technology 40.11%
2 Healthcare 30.69%
3 Financials 23.11%
4 Real Estate 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANSS
1
DELISTED
Ansys
ANSS
$478M 8.37%
1,446,956
-26,669
-2% -$8.45M
INTU icon
2
Intuit
INTU
$98B
$471M 8.25%
1,027,667
-18,484
-2% -$8.09M
WDAY icon
3
Workday
WDAY
$48.1B
$417M 7.31%
1,846,918
-5,577
-0.3% -$1.12M
MA icon
4
Mastercard
MA
$525B
$397M 6.96%
1,010,082
-62,487
-6% -$23.4M
TYL icon
5
Tyler Technologies
TYL
$14.3B
$374M 6.55%
896,921
-16,569
-2% -$6.38M
CSGP icon
6
CoStar Group
CSGP
$13.3B
$348M 6.09%
3,907,967
-117,237
-3% -$9.05M
EW icon
7
Edwards Lifesciences
EW
$52.2B
$345M 6.04%
3,652,973
-451,579
-11% -$39.2M
RMD icon
8
ResMed
RMD
$34.1B
$330M 5.77%
1,508,014
+110,659
+8% +$24.7M
TW icon
9
Tradeweb Markets
TW
$22.8B
$318M 5.58%
4,646,749
-477,189
-9% -$33.8M
VEEV icon
10
Veeva Systems
VEEV
$39.7B
$284M 4.98%
1,438,047
+213,857
+17% +$39M
PTC icon
11
PTC
PTC
$16.4B
$283M 4.96%
1,991,024
-161,144
-7% -$21.3M
MKTX icon
12
MarketAxess Holdings
MKTX
$5.72B
$266M 4.66%
1,018,120
-110,366
-10% -$32.9M
SNPS icon
13
Synopsys
SNPS
$77.3B
$266M 4.66%
610,981
-11,164
-2% -$4.5M
DXCM icon
14
DexCom
DXCM
$34.2B
$244M 4.27%
1,895,846
-34,133
-2% -$4.13M
ICE icon
15
Intercontinental Exchange
ICE
$91B
$208M 3.64%
1,835,125
-339,721
-16% -$36.8M
ILMN icon
16
Illumina
ILMN
$34.1B
$202M 3.53%
1,105,306
-20,374
-2% -$4.12M
TECH icon
17
Bio-Techne
TECH
$11.3B
$186M 3.26%
2,282,104
-42,254
-2% -$3.4M
MSCI icon
18
MSCI
MSCI
$41.2B
$130M 2.27%
+276,116
New +$135M
MTD icon
19
Mettler-Toledo International
MTD
$28.1B
$118M 2.07%
90,157
-1,639
-2% -$2.3M
PODD icon
20
Insulet
PODD
$9.96B
$43.3M 0.76%
150,098
-2,741
-2% -$833K
MRVI icon
21
Maravai LifeSciences
MRVI
$1.3B
– –
-3,800,213
Closed -$53.2M

Similar funds

FAIM
Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return
BAS
Brueske Advisory Services Bellevue, Washington $183M AUM 12.98% 1-Year Est. Return
WAM
WFA Asset Management Whitefish Bay, Wisconsin $184M AUM 12.29% 1-Year Est. Return
SAM
Strive Asset Management Dublin, Ohio $184M AUM 29.16% 1-Year Est. Return
KAH
Kathryn A. Hall $186M AUM 12.55% 1-Year Est. Return
BI
Binnacle Investments Urbandale, Iowa $170M AUM
CWM
Certus Wealth Management Redwood City, California $167M AUM 14.11% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Ownership Capital B.V.'s Q2 2023 Portfolio in Review

As of Q2 2023, Ownership Capital B.V. held 21 positions worth $5.71B, up 0.4% from $5.68B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Ownership Capital B.V.'s Q2 2023 filing shows 1 new, 2 increased, 17 reduced and 1 closed positions. Its largest new stake was MSCI: 276,116 shares worth $130M. The largest sale was Maravai LifeSciences, an estimated $53.2M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Ownership Capital B.V.'s largest Q2 2023 buy was MSCI: 276,116 shares worth $130M.
  • Ownership Capital B.V. added most to Veeva Systems in Q2 2023, an estimated $39M increase.
  • Ownership Capital B.V.'s biggest Q2 2023 reduction was Edwards Lifesciences, cutting an estimated $39.2M.
  • Ownership Capital B.V. fully exited Maravai LifeSciences in Q2 2023, selling an estimated $53.2M.
  • Ownership Capital B.V.'s ten largest holdings make up 66% of its $5.71B portfolio in Q2 2023.
  • Ownership Capital B.V. opened 1 new position and closed 1 in Q2 2023.
  • Ownership Capital B.V.'s portfolio value rose 0.4% quarter-over-quarter to $5.71B.

Based on Ownership Capital B.V.'s 13F filing for Q2 2023, filed 2 Aug 2023.